Keywords
How to Cite
Abstract
On the premise that scientific evidence pointing to the pharmacological properties of Zingiber officinale, the present work, through a literature review carried out in the main databases, such as Periódico da Capes, PubMed, ScienceDirect, Scielo and Cochrane, investigates the activities biological agents that correlate ginger with antiviral action against SARS-CoV-2, the etiological agent of COVID-19. Undoubtedly, the plant has shown to have a range of bioactive compounds with the proposed action, through molecular docking tests which were found to be in the essential oil of the rhizome. These assays demonstrated the metabolite’s ability to bind to several viral components belonging to SARS-CoV-2, such as proteases, Spike protein, RNA binding protein and N-terminal RNA-binding domain, emphasizing an antiviral action. On the other hand, even though science agrees that in Zingiber officinale extracts, there is a possibility of an answer to cure many ailments, which include the promising anti-COVID-19 activity, there is still a lack of in-depth studies on their metabolites, which can serve as an active pharmaceutical ingredient of a new pharmaceutical formulation amid the search for new drugs in the current scenario governed by the pandemic.
References
Estevão A. Covid-19. Acta Radiológica Portuguesa. 2020. 32(1):5-6. ISSN: 2183-1351. [CrossRef].
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine. 2020. 382. ISSN: 727-733. [CrossRef]
Medeiros EAS. Challenges in the fight against the COVID-19 pandemic in University hospitals. Revista Paulista de Pediatria. 2020. 38. ISSN 1984-0462. [CrossRef]
Braga JCB, Silva LR. Consumption of medicinal plants and herbal medicines in Brazil: consumer profile and its relationship with the COVID-19 pandemic. Brazilian Journal of Health Review. 2021. 4(1): 3831-39. ISSN:2595- 6825. [CrossRef]
Silva FGC, Borges ALTF, Oliveira JVL, Prata APN, Porto ICCM, Almeida CAC, et al. Foods, nutraceuticals and medicinal plants used as complementary practice in facing up the coronavirus (Covid-19) symptoms: a review. Scientific Electronic Library Online [online]. 2020; [acesso em 15 abr. 2021]. Disponível em: [Link] [CrossRef]
Safadi MAP. As características intrigantes da COVID-19 em crianças e seu impacto na pandemia. Jornal de Pediatria. 2020. 3(96): 265-68. ISSN-e 0021-7557. [CrossRef].
Uebel RRG. A geopolítica do coronavírus em tempos de incertezas. Revista Diálogos Internacionais. 2020. 7(70). ISSN 2596-2353. [CrossRef]
Brito JCM, Lima WG, Cardoso BG, Simião DC, Amorim JM. Irrational use of medicines and medicinal plants against COVID-19 (SARS-CoV-2): An emerging problem. Brazilian Journal of Health and Pharmacy. 2 (3): 37-53. ISSN: 2596-321x. [CrossRef]
World Health Organization (WHO). Regional Office for Africa. Supports scientifically-proven traditional medicine. Geneva: WHO; 2020. Disponível em: [Link]
Brasil. Ministério da Saúde. A fitoterapia no SUS e o Programa de Pesquisa de Plantas Medicinais da Central de Medicamentos. Brasília, DF: MS. 2006. p.148. [Link]
Hamulka J, Bielak MJ, Górnicka M, Drywién ME, Pukos MAZ. Dietary supplements during COVID-19 outbreak. Results of Google Trends Analysis supported by PLifeCOVID-19 Online Studies. Nutrients. 13(1): 54. INSS: 2072- 6643. [Link]
Chang JS, Wang KC, Yeh CF, Shieh DE, Chiang LC. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. Journal of Ethopharmacology. 2013. 145(1): 146-51. ISSN: 0378-874. [CrossRef]
Bhattacharya R, Dev K, Sourirajan A. Antiviral activity of bioactive phytocompounds against coronavirus: an update. Journal of Virological Methods. 2021. 290 (1). ISSN: 0166-0934. [CrossRef].
Vasconcelos CSS, Feitosa IO, Medrado PLR, Brito APB. O Novo coronavírus e os impactos psicológicos da quarentena. Revista Interdisciplinar da Universidade Federal de Tocantins. 2020. 7 (Supl.): 75-80. ISSN: 2359-3652. [CrossRef]
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research. 2020. 7(11): 1-
ISSN: 2054-9369. [CrossRef]
Mclntosh MDK. COVID-19: Epidemiology, virology, and prevention. Uptodate.[online]. 2021; [Acesso 12 mai. 2021]. Disponível em: [Link]
Beeching N, Fletcher TE, Fowler. Coronavirus disease 2019 (COVID-19). BMJ Best Pract [online]. 2020. [acesso em 20 de ma.2020]. Disponível em: [link]
Rafael RMR, Neto M, Carvalho MMB, David HMSL, Acioli S, Faria MGA. Epidemiologia, políticas públicas e a pandemia da COVID-19: o que esperar no Brasil?. Revista Enfermagem UERJ. 2020. 28(1): 1-6. ISSN: 0104-3552. [CrossRef]
Carvalho AC, Carvalho DF. Consequências do novo coronavírus na economia do Brasil: perspectivas de compreensão econômica e estatística do problema. Papers do Naea. 2020. 1(1). ISSN: 1516-9111. [Link]
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. 588 (E6). ISSN: 1476-4687. [CrossRef]
Gorbalenya AE, Baker SC, Baric RS, Baric RS, Groot RJ, Drosten C, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. 2020. 5 (1): 536-44. ISSN: 2058-5276. [CrossRef]
Musa S. Hepatic and gastrointestinal involvement in coronavírus disease 2019 (COVID-19): what do we know till now?. Arab Journal of Gastroenterology. 2020. 21(1): 3-8. ISS: 1687-1979. [CrossRef].
Montalvo PG, Perales CV, Figueroa LV. Propiedades farmacológicas del jengibre (Zingiber officinale) para la prevención y el tratamiento de COVID-19. Agroindustrial Science. 10(3) 2020. ISSN: 2226-2989. [Link]
Perlman S. Another Decade, Another Coronavirus. The New England Journal of medicine. 2021. 382: 760-762. ISSN: 1533-4406. [Link]
Tang X, Wu C, Li X, Song Y, Yao, X, Duan Y, et al. On the origin and continuing evolution of SARS-CoV-2. National Science Review. 2020. 7(6): 1012- 1023. ISSN: 2095-5138. [CrossRef]
Oliveira WK, Duarte E, França GVA, Garcia LP. Como o Brasil pode deter a COVID-19. Epidemiologia em Serviço de Saúde. 2020. 29(2): e2020044. ISSN: 1679-4974 [Link].
Quintella CM, Quintella HM, Palma GB, Silva SCR, Silva GHR. Coronavírus (SARS-CoV-2) e COVID-19: mapeamento de testes clínicos. Cadernos de Prospecção. 2019. 13(2). ISSN: 1983-1358. [CrossRef]
Organização Mundial da Saúde (OMS). Novo Coronavírus (2019-nCoV): Relatório de situação. 23 de janeiro de 2020. Geneva: WHO; 2020. [Link]
Doremalen NV, Bushmaker, Morris DH, Holbrook MG, Gamble A, Williamson, BN. Aerosol and Surface Stability of SARS-CoV-2 as Compared with ARS-CoV-1. 2020. New England Journal of Medicine. 382(16). ISSN: 1533- 4406. [CrossRef]
Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. 2020. Eurosurveillance. 25(5):pii=2000062. ISSN: 1560-7917. [CrossRef]
Lauer SA. Grantz KH, Qifang B, Forrest JK,Zheng Q, Meredith HR, et al.The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal medicine. 2020. 172: 577-582. 1-37. ISSN: 0003-4819. [CrossRef]
Cassou JD, Beverinotti J, Gaston AL, Francesca C, Emmanuel A, Manzano o, et al. El impacto del COVID en las economías de la región (Región Andina). Banca Interamericano de Desarrollo [online]. 2020; [acesso em 10 maio. 2021]. [CrossRef]
The Global Impact of Respiratory Disease. Forum of Internacional Respiratory Societies [online]. 2017. [acesso em 27 mai. 2021]. Disponível em: [Link]
Instituto Brasileiro de Geografia E Estatística (IBGE). Estudos e Pesquisas: Informação Demográfica e Socioeconômica. Síntese de Indicadores Sociais: uma análise das condições de vida da população brasileira. Rio de Janeiro. 2018. Disponível em: [Link]
Ministério da Saúde (MS). Secretaria de Vigilância em Saúde. Departamento de Análise de Saúde e Vigilância de Doenças Não Transmissíveis. Painel de monitoramento das principais causas de morte, segundo método Global Burden Disease/Brasil. Brasília: Ministério da Saúde; 2017.
Instituto Brasileiro de Geografia E Estatística (IBGE). Cidades e Estados. Rio de Janeiro: IBGE; 2018. Disponível em [Link]
World Health Organization (WHO). Coronavirus disease (COVID-19) situation dashboard. Genebra: WHO; 2021. Disponível em: [Link]
Ministério da Saúde (MS). COVID-19 (painel do Coronavírus) [online]. 2021. [acesso em: 06 de jun. 2021]. Disponível em: [Link]
Chan JF, Yuan S, Kok K, Wang kK, Chu H. Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to- person transmission: a study of a family cluster.The Lancet. 2020. 395(10223):514-523. ISSN: 2666-5247. [CrossRef]
Bajema KL, Oster AM, McGovern OL, Lindstrom S, Strenger MR, Anderson TC, et al. People Evaluated for 2019 Novel Virus-United States, January 2020. Morbidity and Mortality Weekly Report (MMWR). 2020. 69: 166-
ISSN: 0149-2195. [CrossRef]
Zhou F., Yu T., Du R., Fan G, Liu Y, Liu Zhibo, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. TheLancet. 2020. 395(10229):1054-62. ISSN: 2666-
[CrossRef]
Burki T. Understanding variants of SARS-CoV-2. 2021. 397(10273): 462. ISSN: 2666-5247. [CrossRef]
World Wealth Organization (WHO). COVID-19 weekly epidemiological upgrade of january 2021. Geneva: WHO; 2021. Disponível em: [Link]
Martins AF, Zavascki AP, Wink, PL, Volpato FCZ, Monteiro FL, Roset C, et al. Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalization rates in February 2021, Rio Grande do Sul, Southern Brazil [online]; fall [acesso em 15 mar. 2021]. 26(12). Disponívl em: [Link]
Sallas J, Elidio GA, Guilherm DB. A vigilância genômica do SARS-CoV-2 no Brasil na resposta à pandemia da COVID-19. Pan American Journal of Public Health. 2021. 45. ISSN: 1680-5348. [CrossRef]
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020. 8(5):475-81. ISSN: 2213-2600. [CrohanssRef]
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020. 323(11):1061-1069. ISSN: 2574-3805. [Link]
Rangel AM, Noronha LM, Chagas GCL, Meneses GC, Junior GBS, Neto RJP. COVID-19 em China, Itália e Estados Unidos da América: uma breve revisão. Revista de Medicina de São Paulo. 2021. 100(2): 162-70. ISSN: 1679-
[CrossRef][Link]
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. Journal New England of Medicine. 2020. 382(18): 1708-20. ISSN: 1533-4406. [CrossRef]
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV- 2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020. 323(16): 1574. ISSN: ISSN: 2574-3805. [Link]
Santos KB, Batista NJ, Prudencio LPI, Garcia ZB, Goulart JAD. Assistência farmacêutica e o uso irracional de medicamentos frente a COVID- 19: revisão de literatura. Revista Multidisciplinar em Saúde. 2021. 2(1): 31. ISSN: 2675-8008. [CrossRef]
Junior DML, Santis GC, Bordin JO. COVID-19 convalescent plasma transfusion. Hematology, transfusion and Cell Therapy. 2020. 42(2):113-15. ISSN: 2531-1379. [CrossRef]
Medeiros, RONB. Estudo da aplicação na área da saúde do gengibre, sua caracterização química. Portugal; 2017. Dissertação de Mestrado [Programa de Pós-Graduação em Ciências Farmacêuticas] – instituto Superior de Ciências Farmacêuticas Egas Moniz.
Zeni ALB, Parisotto AV, Mattos G, Helena ETS. Utilização de plantas medicinais como remédio caseiro na Atenção Primária em Blumenau, Santa Catarina, Brasil. Revista Ciência e Saúde Coletiva. 2017. 22 (8). ISSN: 1413-
[CrossRef]
Pinheiro DCSN, Leite AKRM, Farias VM, Braga LT, Lopes CAP. Atividade Imunomoduladora das plantas medicinais: perspectivas em medicina veterinária. Ciência Animal. 2003. 13(1): 23-32. ISSN: 0104-3773. [Link]
Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and Chemical Toxicology. 2008. 46(2): 409–420. ISSN: 0278-6915. [CrossRef]
Tonon, FR, Gonçalves GMS. Obtenção de extrato de Zingiber officinale para uso em formulações de uso tópico. In: XVII Encontro de Iniciação Científica. Campinas, Brasil. Universidade Católica de Campinas, 2012.
OLIVEIRA, CT. Caracterização físico química, quantificação do 6- Gingerol e determinação da atividade antioxidante e anti-inflamatória do gengibre (Zingiber officinale). Belo Horizonte, Brasil; 2018. Tese de Doutorado [Programa de Pós-graduação em Ciência deAlimentos] – Faculdade de farmácia da Universidade Federal de Minas Gerais (UFMG).
Moazeni M, Khademolhoseini A. A. Ovicidal effect of the methanolic extract of ginger (Zingiber officinale) on Fasciola hepatica eggs: an in vitro study. Journal of Parasitic Diseases. 2016. 40(3): 662-666. ISSN: 0975-0703 [CrosRef]
Beal, BH. Atividade antioxidante e identificação dos ácidos fenólicos do gengibre (Zingiber officinale Roscoe). Florianópolis, Brasil. Dissertação de Mestrado [Programa de Pós-graduação em Ciência dos Alimentos] - Universidade Federal de Santa Catarina (UFSC).
Zingiber officinale Roscoe [homepage na internet]. TROPICOS. [Link] . Acesso em 24 de mai. 2021.
Blanco EZ. Diversidade genética e química em germoplasma de gengibre (Zingiber officinale). São Paulo, Brasil. 2015. Tese de Doutorado [Área de Pós- graduação em genética e Melhoramento de Plantas] – Universidade de São Paulo. Pernanmuco, 2019. Dissertação de Mestrado [Programa de Pós- graduação em Química] – Univervisade Federal de Sergipe.
Santos JO. Otimização da extração de sesquiterpenos de Zingiber officinale Roscoe e avaliação do seu potencial biológico frente a fatores de virulência e bactérias. 2019. São Cristóvão, Sergipe; 2019. Dissertação de Mestrado [Programa de Pós-graduação em Engenharia Química] – Universidade Federal de Sergipe.
Ras MS, Varoni EM, Selehi B, Rad JS, Mattthews KR, Ayatollahi, et al. Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals: From Tradition to Pharmacy. Molecules. 2017. 22 (12): 2145. ISSN: 1420-3049 [CrossRef]
Vieira NA, Tomiotto FN, Melo GP, Manchope MF, Lima NR, Oliveira GG, et al. Efeito anti-inflamatório do gengibre e possível via de sinalização. 2016. 35(1). ISSN: 1676-5435. [CrossRef]
Carvalho MGS, Bellini JDS, Amaral JLC, Morais LC, Alves LRC, et al. Elderberry, garlic and ginger: antivirals and/or immunostimulants?.2020. Research, Society and Development. 9 (9): ISSN: 2525-3409 [CrossRef]
Khan T, Khan MA, Mashwani ZR, Ullah N, Nadhman A. Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites. Biocatalysis and Agricultural Biotechnology. 2021. 31: 101890. ISSN:1878-8181. [CrossRef]
Ogbole OO, Akinleye TE, Segun PA, Faleye TC, Adenji A. In vitro antiviral activity of twenty-seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses. 2018. 15 (110). ISSN: 1743-422X [Link]
Chang JS, Wang KC, Yeh CF, Shieh DE, Chiang LC. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. Journal of Ethnopharmacology, 2013. 145(5):146-151. ISSN: 0378-8741. [CrossRef]
Patwardhan M, Morgam MT, Dia V, D’Souza D. H. Heat sensitization of hepatitis A virus and Tulane virus using grapeseed extract, gingerol and curcumin. 2020. International Journal Food Microbiology. 90:103461. ISSN: 0740-0020 [CrossRef]
Rasool A, Khan M, Ali M, Anjum A, Amhed I, Aslam A, Nawaz M. Anti- Avian influenza virus H9N2 activity of aqueous extracts of Zingiber officinalis (Ginger) & Allium sativum(Garlic) in chick embryos. 2017. Pakistan Journal of Pharmaceutical Sciences. 30(4): 1341-1344. ISSN: 1011-601X. [Link]
Weng JR, Lin CS, Lai HC, Lin YP, Wang CY, Lin CW. Antiviral activity of Sambucus Formosana Nakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. 2019. Virus Reseach, 273, 197767. ISSN: 0168-1702. [CrossRef]
Ippoushi K, Takeuchi A, Ito H, Horie H, Azuma K. Antioxidative effects of daikon sprout (Raphanus sativus L.) and ginger (Zingiber officinale Roscoe) in rats. 2007. Food Chemistry. 102(1):237-42. ISSN: 0308-8146. [CrossRef]
Dissanayake KGC, Waliwita WALC, Liyanage. A Review on Medicinal Uses of Zingiber officinale (Ginger). 2020. International Journal of Health Sciences and Research. 10(6). ISSN: 2249-9571. [Link]
Kiran G, Karthik L, Devi MSS, Sathiyarajeswaran P, Kanakavalli K, Kumar KM, et al. In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein. Journal of Ayurveda and Integrative Medicine. 2020. 12(2). ISSN: 0975-9476 [CrossRef]
Pandey P, Shinghal D, khan F, Arif M. An in silico screening on piper nigrum, syzygium aromaticum and zingiber officinale roscoe derived compounds against sars‐cov‐2: A drug repurposing approach. Biointerface Research in Applied Chemistry. 2021. 11(4). ISSN: 2069-5837[CrossRef]
Haridas M, Sasidhar V, Nath P, Abhithaj J, Sabu J, Rammanohar P. Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda. Future Journal of Pharmaceutical Sciences. 2021. 7(1): 13. ISSN: 2314-7253. [CrossRef]
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Lucas da Silva Pamplona, Natasha Cristina Silva